1 / 11 / 2012 - PIDTC 2nd Annual Workshop to update on PIDTC protocols for SCID, WAS and CGD, to discuss currents status of newborn screening for SCID and potential for prospective trials for SCID babies.

The Primary Immunodeficiency Treatment Consortium (PIDTC) 2nd Annual Workshop
April 26 ? 28, 2012
Cambridge, Massachusetts

The Primary Immunodeficiency Treatment Consortium (PIDTC) will hold its second annual workshop in Cambridge (MA), April 26-28, 2012. The purpose of the workshop is to update on PIDTC protocols for SCID, WAS and CGD, to discuss currents status of newborn screening for SCID and potential for prospective trials for SCID babies identified at birth, to update on gene therapy trials, to discuss novel approaches to conditioning and strategies to monitor human T and B cell reconstitution, and to offer PIDTC fellowship awardees and young investigators the opportunity to present their findings.

Junior faculty participants are encouraged to submit one abstract (no more than 2 pages) on a topic consistent with the goals of the workshop. Accepted abstracts will be displayed for the entire length of the meeting, and the best ones will be selected for oral presentation.

The USIDNET is proud to sponsor two travel awards to the best abstracts that will be submitted to the workshop by Junior faculty participants.

The abstract submission deadline is approaching ? Jan 20, 2012. Please, submit your abstracts to Luigi D. Notarangelo (luigi.notarangelo@childrens.harvard.edu) and Elizabeth Dunn (DunnE@peds.ucsf.edu).

US Immunodeficiency Network News

1 / 11 / 2012 - PIDTC 2nd Annual Workshop to update on PIDTC protocols for SCID, WAS and CGD, to discuss currents status of newborn screening for SCID and potential for prospective trials for SCID babies.